全部

1·The technology has been the United States patent.

该技术已获美国专利。

2·It is not simply a failure of the United States Patent and Trademark Office (USPTO) to scrutinise applications more rigorously.

这不仅仅是美国专利和商标局(USPTO)缺乏严格的审核程序而导致的失败。

3·Zamboni has applied for a United States patent for diagnosing Multiple Sclerosis, by detecting blood reflux using ultrasound (PCT No.

Zamboni博士已经获得美国多元动脉硬化诊断的专利——通过超声波血液检测法。

4·She drew her data from the United States Patent and Trademark Office (USPTO) -not a perfect indicator of inventiveness, but probably a fair proxy for it.

她从美国专利局和商标局(USPTO)获取并处理数据。USPTO虽然不是一个完美的发明的指标，但是可能是一个发明的公平的代理人。

5·Of the 278,000 patents granted last year by the United States patent office, just 254 went to inventors from Brazil, which accounts for 3% of the world's output and people.

美国专利局去年批准了278，000项专利，其中仅有254项属于巴西投资人。 然而，无论是生产总量还是人口数量，巴西均占到世界的3%。

6·If you are interested in trademark issues I may be talking more about them on this site going forward but definitely visit the United States Patent and trademark Office for more information.

如果大家对商标问题感兴趣，我会在以后给大家介绍，也可以访问美国专利商标局的网站获取更多信息。

7·In the past 12 months, the United States Patent and Trademark Office signed three Memorandums of Understanding with its Chinese counterparts to enhance cooperation on intellectual property issues.

过去12个月里，美国专利商标局与中国方面签订了三份关于加强知识产权合作的备忘录。

8·One of the oddest things to an outsider about the United States patent system is that it is impossible for the U. S. Patent and Trademark Office (PTO) ever to finally reject a patent application.

摘 要：对一个美国专利系统的局外人来说，最奇怪的事情之一就是美国专利和商标局（PTO）不可能最终拒绝一项专利申请。

9·Since China and the United States patent system exists in relatively large differences in the differences, this article on the U. S. patent system, U. S. patent application system more in-depth study.

中美两国在专利制度存在着比较大的差别，本文针对中美专利制度中的申请制度进行了较深入的比较研究。

10·This matters because the price of a given drug falls by more than 85% within a year of patent expiry in competitive markets like the United States.

之所以强调这一点，是因为在美国这样的竞争市场中，某一种药品的价格在专利到期的一年中下滑幅度超过了85%。